191 related articles for article (PubMed ID: 12879985)
1. Bile duct disorders.
Geubel AP; Sempoux C; Rahier J
Clin Liver Dis; 2003 May; 7(2):295-309. PubMed ID: 12879985
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced vanishing bile duct syndrome: response to ursodiol.
O'Brien CB; Shields DS; Saul SH; Reddy KR
Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
[No Abstract] [Full Text] [Related]
3. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
4. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
Srivastava M; Perez-Atayde A; Jonas MM
Gastroenterology; 1998 Sep; 115(3):743-6. PubMed ID: 9721172
[TBL] [Abstract][Full Text] [Related]
5. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
7. Favourable long term effect of ursodeoxycholic acid treatment on congenital vanishing bile duct syndromes.
Karageorgos SA; Tzardi M; Stratakou S; Voumvouraki A; Notas G; Kouroumalis E
Acta Gastroenterol Belg; 2018; 81(2):330-332. PubMed ID: 30024707
[No Abstract] [Full Text] [Related]
8. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced cholestasis.
Levy C; Lindor KD
Clin Liver Dis; 2003 May; 7(2):311-30. PubMed ID: 12879986
[TBL] [Abstract][Full Text] [Related]
10. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.
Smith LA; Ignacio JR; Winesett MP; Kaiser GC; Lacson AG; Gilbert-Barness E; González-Peralta RP; Wilsey MJ
J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):469-73. PubMed ID: 16205517
[No Abstract] [Full Text] [Related]
11. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
12. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
13. Drug and toxin-induced bile duct disorders.
Geubel AP; Sempoux CL
J Gastroenterol Hepatol; 2000 Nov; 15(11):1232-8. PubMed ID: 11129214
[TBL] [Abstract][Full Text] [Related]
14. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
[TBL] [Abstract][Full Text] [Related]
15. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
[TBL] [Abstract][Full Text] [Related]
16. [A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis].
Yoon JY; Min SY; Park JY; Hong SG; Park SJ; Paik SY; Park YM
Korean J Hepatol; 2008 Mar; 14(1):97-101. PubMed ID: 18367862
[TBL] [Abstract][Full Text] [Related]
17. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
Stiehl A; Rudolph G; Sauer P; Benz C; Stremmel W; Walker S; Theilmann L
J Hepatol; 1997 Mar; 26(3):560-6. PubMed ID: 9075663
[TBL] [Abstract][Full Text] [Related]
19. [Cholestasis: drug therapy].
Leuschner U
Praxis (Bern 1994); 1998 Nov; 87(46):1532-6. PubMed ID: 9857764
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
